Differentiating Mesenchymal Stem Cells via 3D Suspension Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for obtaining mesenchymal stem cells from adult tissues are limited by low yield and invasive procedures, necessitating an alternative method for acquiring therapeutically effective amounts for regenerative medicine.
Innovation Solution
A method involving the formation of embryoid bodies from pluripotent stem cells through three-dimensional suspension culture under microgravity, followed by adherent culture in a bioreactor coated with an adhesive polymer to differentiate into mesenchymal stem cells, enhancing proliferation and therapeutic potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If mesenchymal stem cells are isolated from adult tissues, then the cells can be obtained for therapeutic use, but the yield is limited and invasive procedures are required
Solution Approach 1:
The patent applies preliminary action by first forming embryoid bodies from pluripotent stem cells through suspension culture before differentiating them into mesenchymal stem cells. This preliminary formation of embryoid bodies allows for controlled differentiation and high-yield production of therapeutic cells without invasive tissue harvesting
Solution Approach 2:
Instead of the conventional approach of isolating mesenchymal stem cells directly from adult tissues, the patent inverts the process by differentiating mesenchymal stem cells from pluripotent stem cells. This reverse approach eliminates the need for invasive tissue harvesting while providing abundant cell sources for therapy
2Productivity
If three-dimensional suspension culture under microgravity is performed, then high yield of mesenchymal stem cells with superior pharmacological effects is achieved, but the device complexity increases
Solution Approach 1:
The patent transitions from conventional two-dimensional adherent culture to three-dimensional suspension culture under microgravity conditions. This dimensional change enables embryoid body formation and significantly enhances mesenchymal stem cell yield, proliferation rate, and pharmacological effectiveness
Solution Approach 2:
The patent changes the gravity parameter from normal gravitational conditions to microgravity environment using a bioreactor system. This parameter change fundamentally alters cell behavior, promoting embryoid body formation and differentiation into high-yield mesenchymal stem cells with superior therapeutic properties
Data Source
AI summary
The present disclosure relates to a method for producing mesenchymal stem cells from pluripotent stem cells and mesenchymal stem cells prepared by the method. The present disclosure enables mesenchymal stem cells having superior proliferation rate while having superior intrinsic biological activity to be obtained with high yield by sequentially performing three-dimensional suspension culture using pluripotent stem cells, particularly induced pluripotent stem cells (iPSCs), as starting cells and adherent culture of cell aggregates formed therethrough. The mesenchymal stem cells produced by the method of the present disclosure can be usefully used in compositions for treating bone diseases, cartilage diseases or inflammatory and autoimmune diseases owing to high differentiation efficiency into bone and cartilage and superior anti-inflammatory activity.